Sangamo Therapeutics Inc (SGMO) — Free Cash Flow Generation Index
Sangamo Therapeutics Inc (SGMO) has a Free Cash Flow Generation Index of 0.99x as of September 2024. Free cash flow of $11.64 Million represents 1% of operating cash flow ($11.76 Million). Read SGMO total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Free Cash Flow Generation Index (2017–2020)
Historical FCF Generation Index trend for Sangamo Therapeutics Inc across 3 annual periods. Explore SGMO capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Free Cash Flow Generation Index for Sangamo Therapeutics Inc. For the full company profile including market capitalisation, see Sangamo Therapeutics Inc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.91x | $155.16 Million | $169.88 Million | $14.71 Million | ▲ +673.9% |
| 2018 | -0.16x | $-5.91 Million | $37.15 Million | $43.06 Million | ▼ -124.0% |
| 2017 | 0.66x | $7.43 Million | $11.18 Million | $3.75 Million | — |